Aerospacelab is a company established near Brussels aiming at tackling some of the most challenging problems with a completely different paradigm.
EyeD Pharma is a pharmaceutical company dedicated to the development of innovative drug products in ophthalmology. EyeD Pharma focuses on the treatment of glaucoma. Traditionally, glaucoma is treated by administering eye drops every day for the rest of the patient’s life.
PDC*line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. PDC*line Pharma originated from a flagship R&D program of the French Blood Bank (EFS, Etablissement Français du Sang) where PDC*line, a proprietary Plasmacytoid Dendritic Cell line (PDC) was developed from a patient with a PDC leukemia. Laurent LEVY President France & COO, and Joel PLUMAS, CSO founded the company in April 2014 in Grenoble and took the project to the clinical development stage with non-dilutive funding. Eric Halioua joined the team in February 2016, and became President and CEO in July 2016.
Because finding the right partner in the fast-growing digital environment is a hard task, we have built an online multi-criteria searching tool strongly linked to professional networks and peer-to-peer recommendations. Sortlist helps marketing managers find their partners in minutes and let them focus on building communication and marketing success. Start your search now on www.sortlist.com
Developed by and for professionals, Vertuoza construction software makes your life easier and allows you to focus on the essentials of your business. With a single click, you can edit estimates, work schedules, site follow-up and invoicing, wherever you are. Much more than a software Vertuoza is inspired by the words "virtuous" and "virtuose" both in its name and in its philosophy. It's more than just a construction software or a site management application: it's the key to a perfect fit between the different elements of your business. What's more, Vertuoza is a win-win situation. The contractor gains time and efficiency, the client benefits from better service and the architect sees his project in the spotlight.
Imcyse is a clinical stage biopharmaceutical company pioneering the development of a new class of active specific immunotherapies for the treatment of severe chronic autoimmune diseases. The company’s unique technology platform allows it to locally target immune cells involved in the destruction of the diseased organ. This platform is based on the administration of Imotopes™, which are specifically modified peptides, allowing for the generation of cytolytic CD4 T-cells, that specifically eliminate antigen-presenting cells and autoantigen specific lymphocytes. Imcyse’s approach, sustained over time, helps to prevent and treat diseases with no current therapeutic alternative and to potentially cure patients without impairing immune defense. The company has established proof of concept in several indications and has completed its first clinical trial in type 1 diabetes with promising results. Beyond type 1 diabetes, Imcyse is developing a pipeline of Imotopes™ for the treatment of several autoimmune diseases.
Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions, with innovative engineering able to decrease the needs for investments of over 75% and the cost of goods of up to 90%. Univercells' technologies, aimed at low cost manufacturing of antibodies/proteins/vaccines, is based on single-use technologies, and chaining of three manufacturing steps into simulated continuous mode : cell culture under perfusion, clarification and capture.
Syndesi Therapeutics is developing molecules that uniquely modulate the synaptic vesicle protein SV2A, which plays a central role in synaptic transmission (the communication between neurons in the brain). Regulating synaptic transmission represents a promising approach to treating Alzheimer’s Disease and other disorders with cognitive impairment. Syndesi has an exclusive license to its platform technology from UCB, the leading company in SV2A research.
Miracor Medical operates as a medical device company. It develops and commercializes a pressure-controlled intermittent coronary sinus occlusion (PiCSO) impulse system for cardiac surgeons to facilitate the PiCSO treatment for myocardial infarction/heart attack patients undergoing coronary artery bypass grafting surgery. Miracor Medical offers a therapy for improving micro-vascular perfusion functions through the coronary sinus. Werner Mohl founded it in 2008, with its headquarters in Awans in Belgium.
ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections. The company is harnessing a llama-derived antibody technology platform to generate robust antiviral therapies providing broad protection against coronaviruses. They using a highly innovative and clinically validated VHH technology to develop treatments for viral infections that may pose a significant global threat. ExeVir Bio develops a rapid response platform for antivirals. This platform technology enables an agile response to new health threats thanks to its short throughput time to generate drug candidates. The resulting protein-based therapeutics are sufficiently stable and easy to produce at a reasonable cost to enable true global access. ExeVir Bio was founded in 2020 and is headquartered in Zwijnaarde, Belgium.
ITeos Therapeutics is a private biotechnology company targeting the metabolism of the tumor microenvironment to develop small molecule immunomodulators for cancer treatments. iTeos is building its activities upon the unparalleled expertise of the Ludwig Cancer Research (LICR) – a world-class Research Institute in the fields of tumor immunology, therapeutic cancer vaccines, cancer biology, and translational medicine in cancer. iTeos endeavors to develop small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints (e.g. anti-CTLA4, anti-PD1, and anti-PDL1 antibodies).
OncoDNA, with over 60 years’ expertise in medical diagnostics, was founded by a team of experts with many years of experience in DNA sequencing and diagnostic analyses in oncology.
PDC*line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. PDC*line Pharma originated from a flagship R&D program of the French Blood Bank (EFS, Etablissement Français du Sang) where PDC*line, a proprietary Plasmacytoid Dendritic Cell line (PDC) was developed from a patient with a PDC leukemia. Laurent LEVY President France & COO, and Joel PLUMAS, CSO founded the company in April 2014 in Grenoble and took the project to the clinical development stage with non-dilutive funding. Eric Halioua joined the team in February 2016, and became President and CEO in July 2016.
Odoo is an open-source platform that provides integrated business applications for managing various company operations. It includes tools for tasks such as CRM, eCommerce, accounting, and inventory management. The applications are designed to work together, supporting workflows across different departments.
EURA NOVA, founded in 2008, in the midst of the global economic turmoil is a privately-owned company that specializes in digital transformation through AI and data. They offer data consulting, develop custom data solutions (like their Digazu platform), conduct research into emerging technologies, and prioritize a strong, collaborative company culture.
iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium. By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.
Imcyse is a clinical stage biopharmaceutical company pioneering the development of a new class of active specific immunotherapies for the treatment of severe chronic autoimmune diseases. The company’s unique technology platform allows it to locally target immune cells involved in the destruction of the diseased organ. This platform is based on the administration of Imotopes™, which are specifically modified peptides, allowing for the generation of cytolytic CD4 T-cells, that specifically eliminate antigen-presenting cells and autoantigen specific lymphocytes. Imcyse’s approach, sustained over time, helps to prevent and treat diseases with no current therapeutic alternative and to potentially cure patients without impairing immune defense. The company has established proof of concept in several indications and has completed its first clinical trial in type 1 diabetes with promising results. Beyond type 1 diabetes, Imcyse is developing a pipeline of Imotopes™ for the treatment of several autoimmune diseases.
Aerospacelab is a company established near Brussels aiming at tackling some of the most challenging problems with a completely different paradigm.
Minoryx, they are committed to finding innovative treatments for life threatening rare diseases. They focus on pediatric diseases and they are currently working on treatments for neurometabolic diseases of genetic origin.Minoryx develops a new generation of small molecule drugs known as pharmacological chaperones, which offer the most promising approach to the treatment of genetic diseases severely affecting the central nervous system. As a complementary approach, Minoryx is also involved in repositioning-based projects.
WALMAT specialist for the structural work, the completion and the delivery of building materials. WALMAT becomes your best ally in construction and DIY by bringing together Materials Pavilion and Chantiers Beaumontois.
Since 2009, VENYO has been working on a revolutionary B737NG Fixed Base Simulator (FBS) which was revealed and made its “World Premiere” at the Paris Air Show in 2013. It was the very first time that the aeronautical industry was able to view an innovative and fully functional flight simulator operated on site at Le Bourget. Being qualified as a “Game Changer” by the professional community not only confirmed but encouraged VENYO’s intention to continue to invest and move from concept to commercialization. As professionals in aviation training, we’ve understood that high-quality Fixed Base Simulators (FBS) like ours are now in demand to off-load training tasks at an unrivalled budget that would otherwise be done in an expensive Level D Full Flight Simulator (FFS). Designed from day one for the highest level of certification for a motionless training device, we are proud to provide a solution to the pilot shortage with a product allowing you to increase simulator training hours without extra costs. ‘Power-by-the-Hour’ rental model is as some may say a ‘disruptive’ approach to the market. Our flexible, monthly billing includes a minimal contractual number of hours or metered fees (if minimum is exceeded) at a predefined hourly rate. The idea is to offer a simulator at your premises which is constantly maintained to premier standards, with no hidden fees. Our goal is to offer more flexibility for the customer in terms of adjusting to the ongoing market changes in technology and training capacity. Our simulator is easy to install and to operate. It doesn’t require an empty FFS bay and a nuclear power plant nearby. Look at how one of our partners simply installed our training device in a maintenance hangar.
ITeos Therapeutics is a private biotechnology company targeting the metabolism of the tumor microenvironment to develop small molecule immunomodulators for cancer treatments. iTeos is building its activities upon the unparalleled expertise of the Ludwig Cancer Research (LICR) – a world-class Research Institute in the fields of tumor immunology, therapeutic cancer vaccines, cancer biology, and translational medicine in cancer. iTeos endeavors to develop small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints (e.g. anti-CTLA4, anti-PD1, and anti-PDL1 antibodies).
Haulogy is a software company primarily dedicated to distribution system operators and energy providers active in the gas and electricity markets.
ChromaCure will launch a drug development program to identify potential new candidates that selectively and potently inhibit cancer targets and potentially provide novel therapy for multiple forms of cancer, either as monotherapy or in combination with immunotherapy or chemotherapy.
EPICS Therapeutics develop novel therapeutic solutions for cancer, based on the highly innovative field of RNA epigenetics.
EcoPhos is a Belgian based technology provider, producer and market leader of animal feed phosphates in Europe. EcoPhos, with head office and R&D centre in Louvain-La-Neuve, Belgium, employs 250 employees. It has an engineering office (Temco engineering), a full scale (4-8 kt/a) demonstration unit (Technophos) and two feed phosphates production sites (Aliphos) with a total capacity of 300 000 TPA.
Invineo design and development of a "smart machine" for catering and hospitality professionals.
Air Belgium offer quality and attractively priced intercontinental flights to selected markets.
ZenTech is a biotechnology company highly specialised in the diagnostic of pathologies occurring in the early life stages and in the diagnostic of chronic diseases affecting both children and adults.
Synergia Medical aims at developing and commercializing next generation neurostimulation devices. It relies on a seasoned management team with extensive experience in developing implantable neurostimulators. In only three years time, the company became ISO13485 certified, created and sold an OEM external neurostimulator for a motorized amputee prosthesis arm and developed its first version of the NAOS platform. Supported by private investors and public research grants, the company has quickly grown to a team of thirteen highly skilled multidisciplinary professionals.
Syndesi Therapeutics is developing molecules that uniquely modulate the synaptic vesicle protein SV2A, which plays a central role in synaptic transmission (the communication between neurons in the brain). Regulating synaptic transmission represents a promising approach to treating Alzheimer’s Disease and other disorders with cognitive impairment. Syndesi has an exclusive license to its platform technology from UCB, the leading company in SV2A research.
Miracor Medical operates as a medical device company. It develops and commercializes a pressure-controlled intermittent coronary sinus occlusion (PiCSO) impulse system for cardiac surgeons to facilitate the PiCSO treatment for myocardial infarction/heart attack patients undergoing coronary artery bypass grafting surgery. Miracor Medical offers a therapy for improving micro-vascular perfusion functions through the coronary sinus. Werner Mohl founded it in 2008, with its headquarters in Awans in Belgium.
Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.The company uses hiPSC stem cell technology to develop predictive human cellular assay systems for safety and efficacy testing of drug candidates as well as enhance cardiovascular and neural drug screening, enabling researchers to bring predictive human disease biology and accelerate drug discovery.
International Drug Development Institute (IDDI) is an expert clinical trials service provider specialized in biostatistical and integrated eClinical services for pharmaceutical and biotechnology companies in several disease areas, including oncology and ophthalmology. IDDI optimizes the clinical development of drugs, biologics and devices thanks to proven statistical expertise and operational excellence.
Dim3 develops and markets innovative clinical expert platforms and medical devices. Our solutions speed up medical decisions, enhance the life of patients and reduce healthcare costs. Now on the market, DIM3 first platform focuses on the fight against disease-related malnutrition. This is a major but silent threat that costs lives and an estimated 170 billions euros/year for Europe only.
e-peas is a disruptive semiconductor company that enables the seamless operation of all connected nodes. The company is developing ultra-low-power high performances circuits such as energy harvester interfaces and microcontrollers that help companies make their IoT devices smarter and more energy-efficient by either prolonging battery life or making the devices live forever. e-peas also develops energy harvesting solutions which extend rechargeable batteries' life of portable devices by harvesting energy from solar, thermal, vibration, radiofrequency, and other sources. These solutions help industries to build products that free users and industries from a burden of replacing non-rechargeable batteries The company was founded in 2014 and is headquartered in Mont-saint-guibert, Brabant Wallon, Belgium.
Pharmsimple est une parapharmacie en ligne située en Belgique. L’importance de Pharmasimple permet de négocier avec les différents laboratoires partenaires des remises importantes ce qui permet à Pharmasimple de vous proposer des prix très bas.
Elium is the leading European knowledge-sharing solution, bringing together collaboration and knowledge. It allows organisations to capture, structure and access knowledge to help make the right decision and generate impact. Elium integrates seamlessly with Microsoft Sharepoint, Teams, G-Drive, Slack and Workplace by Facebook.
TConcept offers you the perfect brewing appliance, Teh®. This unique device will be launched on the market this year and will be able to provide extraordinary premium tea taste and olfactory sensation by respecting the infusion procedures. The ultimate tea experience. Fully automatic, their appliance provide to the tea an appropriate infusion vessel to enable tea leaves deliver their precious oils and ingredients. In its system, T-Concept has designed and developed a unique brewing apparatus where the internal part of the chamber (called the brewing vessel) is connected to the tea cartridge. Both are tightly sealed. The water is poured in the vessel and (being the cartridge sealed to it) gently flows into the capsule and prevent a thermal shock to raw material. Their brewing appliance has many capacities, including a recognition system by colors which allows him to select the appropriate temperature for each type of tea (each one of them possess her own color). It's also capable of performing an automatic rinsing and a capsule ejection, can display the brewing time, the temperature and the progress percentage for each brewing. And he can do it all with a contemporary design, giving you the feeling of meeting a real tea expert. Their capsules, with their special and transparent packaging, allow you too see the tea, his color and his ingredients and even smell all of his aromas and to make the perfect choice.
Performance for Assets provides a unique solution for analyzing, managing and optimizing process data of a rotating machine.
IONICS develops and supplies technologies and surface coatings especially for metal, glass and other substrates. Our customers are demanding and ambitious, they demand innovative technologies and a responsive service.
Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology. Promethera® Biosciences' mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way using allogenic progenitor cells from healthy human livers. Promethera® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):
Bodair offer you high quality connecting rods and advanced designs that deliver significant weight savings and far surpass the current designs of stainless steel or aluminum rods.
Created in 2000 at the initiative of Professor Georges Daube, this spin-off from the University of Liège is synonymous with innovation and continuous development. Resulting from academic research, Quality Partner Group - Genalyse Partner offers personalized and fast services whose multidisciplinary expertise is the driving force. As a partner in the quality and development of its customers, its goal is to provide a comprehensive response that integrates all their needs, delivering clear, accurate and actionable results to add value. This in keeping with the state of the art. The Quality Partner group is mainly a team of more than 75 people, 250,000 analyzes and 15,000 audits per year in all links of the food chain.
Françoise's Tartes makes simple, honest, homemade cakes and tarts.
Opinum has created and ensures the continuous development of the "Opinum Data Hub" platform, designed for energy and environmental actors. Opinum is the key partner of these actors in their digital transformation journey. Opinum Data Hub covers all stages of the data management value chain to allow its users to look beyond the complexity of data and focus on their core value and expertise. Opinum Data Hub is mainly intended for large private and public service companies, energy suppliers and companies with expertise in energy management (ESCO).
Mydibel offers a wide range of potato products, including fresh, frozen and dry products ranging from cut products to specialty products. puree.
Nyxoah is a health-technology company focused on the development and commercialization of innovative solutions and services to treat sleep disordered breathing conditions. Nyxoah's lead solution platform is based on the Genio® system, a validated, user-centered, next generation neurostimulation therapy for OSA, the world's most common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
ISSOL is a manufacturer and developer of active materials and glazing. The company operates in the construction sector and the glass industry. Its mission is to develop solutions that communicate emotion and contribute to the sustainable image needs of its customers.
Diagenode is an international life sciences company that develops and commercializes innovative instruments and reagents systems for life science research and molecular diagnostics. Founded in 2003 in Liege (Belgium), Diagenode is a global company, with headquarters in Liege, Belgium and Sparta, NJ, USA. Diagenode also has a local sales office in the United Kingdom to better serve this specific country. Diagenode's customers include leading epigenetics researchers, academic institutions, high-profile genome centers and core labs, life sciences tools companies, molecular diagnostics players, and pharmaceutical and biotechnology companies. Epigenetics Division
Scidus develops products: Torréfié® wood , Cloisobois® , machined logs , double curvature hulls and beech boards .
In conferences and debates, waiting for the wireless microphone in order to ask questions can be quite disruptive or even so slow that it ruins the flow of interactions. Keybate intends to solve this problem by turning the smartphones of every conference’s attendees into high-quality wireless microphones connected to every conference room's AV system. The app allows each attendee to request the floor and speak at the touch of a finger. The mobile app also allows attendees to send text questions, answer live polls, and interact with other attendees, either directly or through social networks. Keybate will be the essential companion for every conference attendee.
iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium. By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.
Opinum has created and ensures the continuous development of the "Opinum Data Hub" platform, designed for energy and environmental actors. Opinum is the key partner of these actors in their digital transformation journey. Opinum Data Hub covers all stages of the data management value chain to allow its users to look beyond the complexity of data and focus on their core value and expertise. Opinum Data Hub is mainly intended for large private and public service companies, energy suppliers and companies with expertise in energy management (ESCO).
TSF BE design, manufacture, rental and sale of shooting, lighting, machinery and consumables for film and television.
Paprika is a privately held company that operates a chain of fashion stores that retails collection for fashion-minded larger-sized women.
Any-Shape is a company dedicated to Additive Technologies (3D printing) for industry with production capabilities including plastic, metal & composites materials.
Decube group is active in the technical and industrial trades such as engineering, assembly and industrial painting.
Opinum has created and ensures the continuous development of the "Opinum Data Hub" platform, designed for energy and environmental actors. Opinum is the key partner of these actors in their digital transformation journey. Opinum Data Hub covers all stages of the data management value chain to allow its users to look beyond the complexity of data and focus on their core value and expertise. Opinum Data Hub is mainly intended for large private and public service companies, energy suppliers and companies with expertise in energy management (ESCO).
Ogeda (formerly named Euroscreen) is a Belgium-based, privately owned clinical-stage drug discovery company that invents and develops small molecule drug candidates targeting GPCRs. Ogeda's orally-available and proprietary lead drug candidate fezolinetant (ESN364) is currently in Phase2 clinical development for the treatment of women's health disorders. Ogeda has additional small molecules targeting GPCRs in pre-clinical development in multiple therapeutic areas including inflammatory and autoimmune diseases. Ogeda is backed by leading investors, including Vealius Biocapital II SA Sicar, Fund+ NV, SRIW SA, Capricorn Health-Tech Fund NVHT fund, BNP Paribas Fortis Private Equity Management SA. For more information, please visit: www.ogeda.com
CluePoints® is a Risk-Based Monitoring and Central Statistical Monitoring solution that has been designed and perfected over the last 15 years. It employs unique statistical algorithms to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the ICH, FDA and EMA, CluePoints® is deployed to support traditional on-site monitoring, medical review and to drive a Risk-Based Monitoring strategy. The value of using CluePoints® lies in its powerful and timely ability to identify anomalous data and site errors allowing improvement in clinical data quality, optimization of on-site monitoring and a significant reduction in overall regulatory submission risk.
Mithra Pharmaceuticals SA specializes in the development of women's health care products that are dedicated to the fields of contraception, fertility, and menopause. The two lead development candidates Estelle® (a fifth generation oral contraceptive) and Donesta® (a next generation hormone therapy) are built on Mithra's unique natural estrogen platform, E4 (Estetrol).
ChanvrEco S.A. is an International Trade and Development company located in 8 Rue du Centre, Tinlot, Walloon Region, Belgium.
AMOS design and manufacture of very-high-accuracy optomechanical systems for the space industry and for professional astronomy. AMOS is active in three main areas: • Professional astronomy systems: telescopes, components and instrumentation for many of the world’s largest observatories. • Space systems: on-board installations for satellites, probes and space shuttles – telescopes, mirrors, mounts, frameworks and mechanisms. • Terrestrial satellite test equipment to validate satellites or payloads under space conditions prior to launch: vacuum chambers, thermal panels and ‘artificial stars’ (collimators).
Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.The company uses hiPSC stem cell technology to develop predictive human cellular assay systems for safety and efficacy testing of drug candidates as well as enhance cardiovascular and neural drug screening, enabling researchers to bring predictive human disease biology and accelerate drug discovery.
Proxistore is a developer advertising platform for large retail chains and small businesses.
IBA engages in the distribution of crop protection and cattle feed products.
LASEA designs and manufactures workstations and special machines to respond to the applications of marking, engraving, cutting, drilling, texturing, thin film removal, welding and micromachining.
Odoo is an open-source platform that provides integrated business applications for managing various company operations. It includes tools for tasks such as CRM, eCommerce, accounting, and inventory management. The applications are designed to work together, supporting workflows across different departments.
Pierret is a manufacturer of PVC, aluminum, wood and aluminum-wood exterior joinery, has been highlighting quality. Engineers do not make concessions in the field of Research & Development. The innovations and technologies developed guarantee doors and windows that meet the highest standards and certifications on the market. The resistance to air, water and wind, therefore the weather, the acoustic properties and the break-in resistance of Pierret doors and windows are tested in certified and independent laboratories.
Fruytier group, part of the TOP20 of European softwood processors, has fully mastered the process of the timber industry from sourcing of round wood all the way to the delivery of the finished product. Fruytier Group provides its partners with sawn wood for structures, packaging industry, siding and outside decking in Spruce and Douglas Fir from mainly local timber sources (FSC®/PEFC). Fruytier Group is a reliable partner as well for sawmill by-products such as pellets for heating, sawdust, chips and bark. Fruytier Group services include: – Sawing & grading – CE marking – High precision re-cutting – Drying, planing & moulding – Dipping and high pressure impregnation – Glueing & fingerjointing Ideally located in the heart of Europe, Fruytier Group is able to supply large quantities of high quality products with short leadtimes. Fruytier Group processes over 1 million m³ per year on our sites in Belgium, Germany and France. A wide range of softwood products through one single contact!
Trendy Foods Belgium is a distribution of confectionery products.
iSTAR Medical SA was created in 2010 as a spinout of Healionics Corporation with support from Belgium's Region Wallonne government. In 2011, iSTAR expanded to its new eco-friendly R&D and Manufacturing facility in CREALYS Scientific Park near Namur, Belgium. By 2012, iSTAR received ISO 13485 and ISO 9001 Quality Systems Certifications and achieved CE Mark approval of its first device - STARflo™ Glaucoma Implant.
Allmat is the first Walloon group of generalist trades in building materials, wood and professional tools which operates 13 stores under the Allmat brand in Andenne, Ciney, Beauraing, Dinant, Marche, Melreux, Cognelée, Floreffe, Libramont, Bièvre, Orp, Nalinnes and Seraing and SA BOISMAT wood specialist.
Lampiris, an independent supplier of gas, green power and energy services such as insulation, furnace maintenance, wood and pellets for heating, and smart thermostats, has been active in the Belgian energy market since 2005. Lampiris, which currently supplies more than a million accounts, is the third-largest supplier in the residential energy market in Belgium.
ICARUS SA is a single source supplier of complete piping packages and manufacturer of specialty valves and tailor made products for onshore, offshore and subsea applications.
KitoZyme designs, manufactures and markets medical devices, food supplements and oenological ingredients from non-animal chitosan and chitin-glucan. KitoZyme is focused on providing solutions and outstanding services to our customers. KitoZyme is renowned for continually delivering new products and closely assisting our clients at every moment. Forever innovating, we are the long term partner that successfully produces complete solutions and helps create the future portfolios of clients all over the world. These solutions mainly come in the form of medical devices that are based on unique and patented technologies, namely chitosan and chitin-glucan manufactured from non-animal and non-GMO sources. Both the performance and safety of all of these technologies are scientifically and clinically proven.
Private Equity Round in 2012
Ogeda (formerly named Euroscreen) is a Belgium-based, privately owned clinical-stage drug discovery company that invents and develops small molecule drug candidates targeting GPCRs. Ogeda's orally-available and proprietary lead drug candidate fezolinetant (ESN364) is currently in Phase2 clinical development for the treatment of women's health disorders. Ogeda has additional small molecules targeting GPCRs in pre-clinical development in multiple therapeutic areas including inflammatory and autoimmune diseases. Ogeda is backed by leading investors, including Vealius Biocapital II SA Sicar, Fund+ NV, SRIW SA, Capricorn Health-Tech Fund NVHT fund, BNP Paribas Fortis Private Equity Management SA. For more information, please visit: www.ogeda.com
EURODV design, manufacture and installation of doors and partitions -pleines, glass, high performance métalliques.
SPACEBEL is a space systems and software engineering company active in the space sector and earth observation applications, serving space agencies, prime contractors, European institutions and the commercial sector.
ITeos Therapeutics is a private biotechnology company targeting the metabolism of the tumor microenvironment to develop small molecule immunomodulators for cancer treatments. iTeos is building its activities upon the unparalleled expertise of the Ludwig Cancer Research (LICR) – a world-class Research Institute in the fields of tumor immunology, therapeutic cancer vaccines, cancer biology, and translational medicine in cancer. iTeos endeavors to develop small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints (e.g. anti-CTLA4, anti-PD1, and anti-PDL1 antibodies).
Dragone is a creative company, human talents, artistic disciplines and technical innovations to bring stories alive.
GreenWatt is an established CleanTech company offering full engineering services, covering feasibility study conception, construction and starting up of turn key small scale biogas plants around innovative and unique patented technologies solving all key issues of anaerobic digestion.
Rentel is a Belgian knowledge centre for offshore wind energy that develops, finances, constructs and operates offshore wind parks in Belgian North Sea and possibly also abroad.
Alysse Food manufactures bakery products in Brussels for bagels, muffins and brownies.
Eurogare sa is a design office specializing in the technical study, monitoring and implementation of railway and architectural projects: terminals and railway infrastructure, signal booths, infrastructure logistics centers, workshops, car parks, offices.
Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology. Promethera® Biosciences' mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way using allogenic progenitor cells from healthy human livers. Promethera® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):
XyloWatt specializes in the design, construction and management of cogeneration plants that use gasification of natural wood and recycled wood.
Carmeuse is a global producer of lime, high calcium limestone and dolomitic stone dedicated to many different uses.
intoPIX is creating and implementing leading-edge image and video compression, security , video transport FPGA/ASIC IP-cores and Software solutions for audiovisual applications. Their unique implementation provides today’s highest quality, most flexible and cost effective handling tools for managing high throughput data streams. intoPIX IP-cores are dedicated to Digital Cinema, Broadcast, Pro-AV, VR/AR, Wireless, Medical, Aerospace, Automotive, Vision, Security and any other applications where image quality is a crucial asset. IntoPIX is an independent and innovative image technology company which benefits from world-class expertise and knowledge in image processing, cryptography and micro-electronics. Our wide range of technologies features JPEG 2000 encoders and decoders, TICO lightweight compression (SMPTE RDD35), JPEG-XS compression video and network interfaces (MPEG2-TS for SMPTE2022, Ethernet-AVB), multimedia and encryption functions (AES, RSA, SHA,...), memory controllers, and more.
IPEX has always focused on key concepts: personalization - identification - traceability - customer service. Ipex distinguishes itself by offering IT data management over 3 product ranges: The stickers Transaction documents Promotional documents
EHP develops Two-Phase solutions that enables optimized spacecrafts and payloads thermal architecture. EHP works all along in concurrent engineering with its customers to propose standard and customized products providing innovative, reliable, robust and qualified thermal solutions.
CISSOID is a Fabless Semiconductor company, leader in High Temperature Electronics. They develop and sell Integrated Circuits (IC) designed for the highest reliability in the widest range of temperatures. Their products will operate at least from -55°C to +225°C. They have been tested from -200°C to +300°C. The reliability of CISSOID products is based on long years of experience in silicon technologies, design for reliability, assembly techniques and test. CISSOID products are commonly used under extreme conditions and harsh environments, for example in demanding Oil&Gas, Aerospace and Automotive applications. They enable exploitation of deep oil resources, energy savings in aircrafts and automobiles, optimal exploitation of geothermal resources, etc. CISSOID proposes a portfolio of High Temperature standard products, such as Voltage Regulators, Voltage References, Clock Generators & Timers, Analog-to-Digital Converters, Amplifiers, High-Voltage MOSFET's and Drivers. Custom solutions can also be developed as an Application Specific Monolithic IC (ASIC) or as a Hybrid multichip assembly solution. Most of CISSOID’s products are built on Silicon-on-Insulator (SOI), a fabrication process that offers tremendous advantages for High Temperature operation and high levels of radiation (Rad-Hard products). Cissoid’s products inherit over 20 years of R&D activities in the field of SOI and was the very first company to exploit this technology. CISSOID produces: DC-DC converters (High Temperature) Linear Voltage Regulators (High Temperature) MOSFET and Switches (High Temperature) Oscillators and Timers (High Temperature) Motor Drivers ((High Temperature) Logic Gates (High Temperature) Operational Amplifiers (High Temperature) Analog-to-DIgital Converters (High Temperature)
Synthetis, at the exclusive service of the industrial world, quickly brings a durable and customized IT solution to optimize production processes
VIRIDAXIS, a spin‑off of Louvain Catholic University, uses an innovative technology to mass-produce parasitoids. These are then supplied to Belgian and multinational companies operating in this sector. Expansion of its R&D activity now enables the company to develop new products and increase its production capacity.
Cosucra produces natural food ingredients to food manufactures.
Celyad is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T NKR-2, C-Cure. The firm has CYAD-01, CYAD-02, CYAD-03 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Immuno-oncology operating segments.